These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37183108)

  • 21. Comparison of laparoscopic hepatectomy, percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma.
    Lai C; Jin RA; Liang X; Cai XJ
    J Zhejiang Univ Sci B; 2016 Mar; 17(3):236-46. PubMed ID: 26984844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma.
    Guo WX; Sun JX; Cheng YQ; Shi J; Li N; Xue J; Wu MC; Chen Y; Cheng SQ
    World J Surg; 2013 Mar; 37(3):602-7. PubMed ID: 23212793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application value of laparoscopic radiofrequency ablation for specific-location hepatocellular carcinoma].
    Shi HD; Shi XJ; Ma HX; Liang YR; Zhou L; Shi Y
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):56-59. PubMed ID: 28104035
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan W; Deng Q; Lin S; Wang Y; Xu G
    Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation.
    Ali MAM; Harmsen WS; Morsy KH; Galal GMK; Therneau TM; Roberts LR
    BMC Cancer; 2022 Feb; 22(1):221. PubMed ID: 35227234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma.
    Liu J; Shen H; Huang S; Lin J; Yan Z; Qian G; Lu Z; Wan X; Zhang F; Wang K; Zhang Y; Li J
    World J Surg Oncol; 2023 Feb; 21(1):42. PubMed ID: 36765340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.
    Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH
    Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience.
    de la Serna S; Vilana R; Sánchez-Cabús S; Calatayud D; Ferrer J; Molina V; Fondevila C; Bruix J; Fuster J; García-Valdecasas JC
    HPB (Oxford); 2015 May; 17(5):387-93. PubMed ID: 25545319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
    Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
    JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation.
    Yazici P; Akyuz M; Yigitbas H; Dural C; Okoh A; Aydin N; Berber E
    Surg Endosc; 2017 Mar; 31(3):1269-1274. PubMed ID: 27444839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma.
    Hsieh CB; Chang HM; Chen TW; Chen CJ; Chan DC; Yu JC; Liu YC; Chang TM; Shen KL
    World J Gastroenterol; 2004 Feb; 10(4):505-8. PubMed ID: 14966906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic combined with percutaneous ablation for hepatocellular carcinoma under liver capsule: A single Chinese center experience of thirty patients.
    Tang Z; Zhu Y; Tang K; Dong L; Yang B; Fang H; Wu Y; Zhang B
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C143-C147. PubMed ID: 28230007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic US-guided radiofrequency ablation of unresectable hepatocellular carcinoma in liver cirrhosis: feasibility and clinical outcome.
    Casaccia M; Andorno E; Nardi I; Troilo B; Barabino G; Santori G; Valente U
    J Laparoendosc Adv Surg Tech A; 2008 Dec; 18(6):797-801. PubMed ID: 18922065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Study of Long-Term Outcomes of Laparoscopic Liver Resection versus Radiofrequency Ablation for Single Small Hepatocellular Carcinoma Located in Left Lateral Segments of the Liver.
    Kang M; Cho JY; Han HS; Yoon YS; Lee HW; Lee B; Park Y; Kim J; Yoon CJ
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374267
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yen YH; Li WF; Wang CC; Lu SN; Kee KM; Yong CC; Cheng YF; Wang JH; Hu TH; Hung CH; Chen CH
    Surg Oncol; 2022 Jun; 42():101769. PubMed ID: 35468499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.